期刊文献+

局部晚期、局部复发食管癌的三维适形放疗加同期增敏化疗的研究 被引量:2

下载PDF
导出
摘要 目的观察局部晚期、局部复发食管癌的三维适形放疗加同期增敏化疗的疗效。方法 90例局部晚期或局部复发食管癌患者,随机分为A、B2组。A组50例给予三维适形放疗加同期增敏化疗;B组40例给予常规放疗加同期增敏化疗。结果 (近期疗效):A组:CR24%.PR72.0%,总有效率达96%;B组:CR22.5%,PR68.2%,总有效率达90.7%。远期疗效2年生存率分别为52%、37.5%。结论本方法可以明显提高局部晚期食管癌患者的局部控制率。
出处 《中国现代药物应用》 2010年第18期125-125,共1页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献2

二级参考文献8

共引文献98

同被引文献45

  • 1王晓稼,陈占红,叶魏武,楼彩金.卡培他滨治疗消化道恶性肿瘤的药物经济学评价[J].中国药房,2005,16(2):115-117. 被引量:6
  • 2Akutsu Y, Shuto K, Kono T, et al. A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma. Hepatogastroenterology. 2012;59(119): 2095-2098.
  • 3Fencl P, Belohlavek O, Harustiak T, et al. The analysis of factors affecting the threshold on repeated 18F-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma. Nucl Med Commun. 2012; 33(11) 1188-1194.
  • 4Ji Y, Zheng MF, Ye SG, et al. Agrocybe aegerita polysaccharide combined with chemotherapy improves tumor necrosis factor-a and interferon-~ levels in rat esophageal carcinoma. Dis Esophagus. 2013;26(8):859- 863.
  • 5Kobayashi N, Nakayama H, Osaka Y, et al. Tumor response after 10w-dose preoperative radiotherapy combined with chemotherapy for squamous cell esophageal carcinoma. Anticancer Res. 2013;33(3):1157-1161.
  • 6Choi N, Park SD, Lynch T, et al. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Int J Radiat Oncol Biol Phys. 2004;60(1):111-122.
  • 7Kim MK, Cho K J, Park SI, et al. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009; 75(1):115-121.
  • 8Akutsu Y, Kono T, Uesato M, et al. S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinoma. Oncology 2013;84(5):305-310.
  • 9Koo DH, Park SI, Kim YH, et al. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Cancer Chemother Pharmacol. 2012;69(3):655-663.
  • 10黄盛东,刘晓红,袁扬,龚德军.食管癌中p75^(NTR)阳性细胞池的变化与顺铂耐药机制的研究[J].中华实验外科杂志,2007,24(12):1560-1562. 被引量:9

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部